Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies
Journal of Thrombosis and Haemostasis2017Vol. 15(5), pp. 835–847
Citations Over TimeTop 1% of 2017 papers
Joseph J. Shatzel, Samuel R. Olson, Dengshun Tao, Owen J. T. McCarty, Alexey V. Danilov, Thomas G. DeLoughery
Related Papers
- → Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions(2021)6 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)